BlackRock’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $607K | Sell |
374,763
-109,743
| -23% | -$178K | ﹤0.01% | 4330 |
|
|
2025
Q1 | $348K | Sell |
484,506
-3,857
| -0.8% | -$2.77K | ﹤0.01% | 4436 |
|
|
2024
Q4 | $542K | Buy |
488,363
+709
| +0.1% | +$787 | ﹤0.01% | 4341 |
|
|
2024
Q3 | $341K | Sell |
487,654
-10,042
| -2% | -$7.03K | ﹤0.01% | 4362 |
|
|
2024
Q2 | $498K | Sell |
497,696
-1,749,762
| -78% | -$1.75M | ﹤0.01% | 4293 |
|
|
2024
Q1 | $5.33M | Sell |
2,247,458
-3,953
| -0.2% | -$9.37K | ﹤0.01% | 3588 |
|
|
2023
Q4 | $5.07M | Buy |
2,251,411
+144,542
| +7% | +$325K | ﹤0.01% | 3614 |
|
|
2023
Q3 | $4.47M | Sell |
2,106,869
-57,863
| -3% | -$123K | ﹤0.01% | 3640 |
|
|
2023
Q2 | $6.69M | Buy |
2,164,732
+1,697,134
| +363% | +$5.24M | ﹤0.01% | 3520 |
|
|
2023
Q1 | $2.52M | Buy |
467,598
+230,327
| +97% | +$1.24M | ﹤0.01% | 3865 |
|
|
2022
Q4 | $1.58M | Sell |
237,271
-200,350
| -46% | -$1.33M | ﹤0.01% | 4159 |
|
|
2022
Q3 | $1.74M | Sell |
437,621
-2,497
| -0.6% | -$9.94K | ﹤0.01% | 4171 |
|
|
2022
Q2 | $2.19M | Sell |
440,118
-909,127
| -67% | -$4.52M | ﹤0.01% | 4135 |
|
|
2022
Q1 | $8.15M | Sell |
1,349,245
-54,082
| -4% | -$327K | ﹤0.01% | 3613 |
|
|
2021
Q4 | $16.3M | Buy |
1,403,327
+273,289
| +24% | +$3.18M | ﹤0.01% | 3336 |
|
|
2021
Q3 | $17.7M | Buy |
1,130,038
+356,413
| +46% | +$5.59M | ﹤0.01% | 3312 |
|
|
2021
Q2 | $14.4M | Buy |
773,625
+5,809
| +0.8% | +$108K | ﹤0.01% | 3426 |
|
|
2021
Q1 | $33.1M | Buy |
+767,816
| New | +$33.1M | ﹤0.01% | 2847 |
|